These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 23239525)

  • 21. D2/D3 dopamine receptor binding with [F-18]fallypride correlates of executive function in medication-naïve patients with schizophrenia.
    Vyas NS; Buchsbaum MS; Lehrer DS; Merrill BM; DeCastro A; Doninger NA; Christian BT; Mukherjee J
    Schizophr Res; 2018 Feb; 192():442-456. PubMed ID: 28576546
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Validation of the octamouse for simultaneous 18F-fallypride small-animal PET recordings from 8 mice.
    Rominger A; Mille E; Zhang S; Böning G; Förster S; Nowak S; Gildehaus FJ; Wängler B; Bartenstein P; Cumming P
    J Nucl Med; 2010 Oct; 51(10):1576-83. PubMed ID: 20847158
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitative PET analysis of the dopamine D2 receptor agonist radioligand 11C-(R)-2-CH3O-N-n-propylnorapomorphine in the human brain.
    Otsuka T; Ito H; Halldin C; Takahashi H; Takano H; Arakawa R; Okumura M; Kodaka F; Miyoshi M; Sekine M; Seki C; Nakao R; Suzuki K; Finnema S; Hirayasu Y; Suhara T; Farde L
    J Nucl Med; 2009 May; 50(5):703-10. PubMed ID: 19372485
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Measurement of d-amphetamine-induced effects on the binding of dopamine D-2/D-3 receptor radioligand, 18F-fallypride in extrastriatal brain regions in non-human primates using PET.
    Mukherjee J; Christian BT; Narayanan TK; Shi B; Collins D
    Brain Res; 2005 Jan; 1032(1-2):77-84. PubMed ID: 15680944
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Decreased dopamine D2/D3-receptor binding in temporal lobe epilepsy: an [18F]fallypride PET study.
    Werhahn KJ; Landvogt C; Klimpe S; Buchholz HG; Yakushev I; Siessmeier T; Müller-Forell W; Piel M; Rösch F; Glaser M; Schreckenberger M; Bartenstein P
    Epilepsia; 2006 Aug; 47(8):1392-6. PubMed ID: 16922886
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of amphetamine on [(18)F]fallypride in vivo binding to D(2) receptors in striatal and extrastriatal regions of the primate brain: Single bolus and bolus plus constant infusion studies.
    Slifstein M; Narendran R; Hwang DR; Sudo Y; Talbot PS; Huang Y; Laruelle M
    Synapse; 2004 Oct; 54(1):46-63. PubMed ID: 15300884
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rostrocaudal gradients of dopamine D2/3 receptor binding in striatal subregions measured with [(11)C]raclopride and high-resolution positron emission tomography.
    Alakurtti K; Johansson JJ; Tuokkola T; Någren K; Rinne JO
    Neuroimage; 2013 Nov; 82():252-9. PubMed ID: 23727314
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Brain and plasma pharmacokinetics of aripiprazole in patients with schizophrenia: an [18F]fallypride PET study.
    Gründer G; Fellows C; Janouschek H; Veselinovic T; Boy C; Bröcheler A; Kirschbaum KM; Hellmann S; Spreckelmeyer KM; Hiemke C; Rösch F; Schaefer WM; Vernaleken I
    Am J Psychiatry; 2008 Aug; 165(8):988-95. PubMed ID: 18381901
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of acute detoxification of the herbal blend 'Spice Gold' on dopamine D2/3 receptor availability: a [18F]fallypride PET study.
    Rominger A; Cumming P; Xiong G; Koller G; Förster S; Zwergal A; Karamatskos E; Bartenstein P; La Fougère C; Pogarell O
    Eur Neuropsychopharmacol; 2013 Nov; 23(11):1606-10. PubMed ID: 23452563
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased cerebral blood flow after single dose of antipsychotics in healthy volunteers depends on dopamine D2 receptor density profiles.
    Selvaggi P; Hawkins PCT; Dipasquale O; Rizzo G; Bertolino A; Dukart J; Sambataro F; Pergola G; Williams SCR; Turkheimer F; Zelaya F; Veronese M; Mehta MA
    Neuroimage; 2019 Mar; 188():774-784. PubMed ID: 30553916
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The relationship between excitement symptom severity and extrastriatal dopamine D
    Joo YH; Kim JH; Son YD; Kim HK; Shin YJ; Lee SY; Kim JH
    Eur Arch Psychiatry Clin Neurosci; 2018 Sep; 268(6):529-540. PubMed ID: 28623450
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The distribution of D2/D3 receptor binding in the adolescent rhesus monkey using small animal PET imaging.
    Christian BT; Vandehey NT; Fox AS; Murali D; Oakes TR; Converse AK; Nickles RJ; Shelton SE; Davidson RJ; Kalin NH
    Neuroimage; 2009 Feb; 44(4):1334-44. PubMed ID: 19015034
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Parametric Imaging and Test-Retest Variability of ¹¹C-(+)-PHNO Binding to D₂/D₃ Dopamine Receptors in Humans on the High-Resolution Research Tomograph PET Scanner.
    Gallezot JD; Zheng MQ; Lim K; Lin SF; Labaree D; Matuskey D; Huang Y; Ding YS; Carson RE; Malison RT
    J Nucl Med; 2014 Jun; 55(6):960-6. PubMed ID: 24732151
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute effect of intravenously applied alcohol in the human striatal and extrastriatal D
    Pfeifer P; Tüscher O; Buchholz HG; Gründer G; Vernaleken I; Paulzen M; Zimmermann US; Maus S; Lieb K; Eggermann T; Fehr C; Schreckenberger M
    Addict Biol; 2017 Sep; 22(5):1449-1458. PubMed ID: 27396374
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of extrastriatal D2 in vivo specific binding of [¹⁸F](N-methyl)benperidol using PET.
    Eisenstein SA; Koller JM; Piccirillo M; Kim A; Antenor-Dorsey JA; Videen TO; Snyder AZ; Karimi M; Moerlein SM; Black KJ; Perlmutter JS; Hershey T
    Synapse; 2012 Sep; 66(9):770-80. PubMed ID: 22535514
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo affinity of [18F]fallypride for striatal and extrastriatal dopamine D2 receptors in nonhuman primates.
    Slifstein M; Hwang DR; Huang Y; Guo N; Sudo Y; Narendran R; Talbot P; Laruelle M
    Psychopharmacology (Berl); 2004 Sep; 175(3):274-86. PubMed ID: 15024551
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Imaging dopamine D3 receptors in the human brain with positron emission tomography, [11C]PHNO, and a selective D3 receptor antagonist.
    Searle G; Beaver JD; Comley RA; Bani M; Tziortzi A; Slifstein M; Mugnaini M; Griffante C; Wilson AA; Merlo-Pich E; Houle S; Gunn R; Rabiner EA; Laruelle M
    Biol Psychiatry; 2010 Aug; 68(4):392-9. PubMed ID: 20599188
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact of common dopamine D2 receptor gene polymorphisms on D2/3 receptor availability: C957T as a key determinant in putamen and ventral striatum.
    Smith CT; Dang LC; Buckholtz JW; Tetreault AM; Cowan RL; Kessler RM; Zald DH
    Transl Psychiatry; 2017 Apr; 7(4):e1091. PubMed ID: 28398340
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differentiation of extrastriatal dopamine D2 receptor density and affinity in the human brain using PET.
    Olsson H; Halldin C; Farde L
    Neuroimage; 2004 Jun; 22(2):794-803. PubMed ID: 15193608
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Opiate-induced dopamine release is modulated by severity of alcohol dependence: an [(18)F]fallypride positron emission tomography study.
    Spreckelmeyer KN; Paulzen M; Raptis M; Baltus T; Schaffrath S; Van Waesberghe J; Zalewski MM; Rösch F; Vernaleken I; Schäfer WM; Gründer G
    Biol Psychiatry; 2011 Oct; 70(8):770-776. PubMed ID: 21802658
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.